Search

Author/Creator Patriarca, F.

1. PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS. (23rd June 2022)

Authors:
Bruzzese, A.; Derudas, D.; Galli, M.; Martino, E. A.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangicavalli, S.; Farina, G.; Lombardo, A.; Brunori, M.; Rossi, E.; Antonioli, E.; Ria, R.; Zambello, R.; Di Renzo, N.; Mele, G.; Marcacci, G.; Pietrantuono, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1856
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prognostic factors and outcome of Epstein–Barr virus DNAemia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. Issue 3 (13th February 2013)

Authors:
Patriarca, F.; Medeot, M.; Isola, M.; Battista, M.L.; Sperotto, A.; Pipan, C.; Toffoletti, E.; Dozzo, M.; Michelutti, A.; Gregoraci, G.; Geromin, A.; Cerno, M.; Savignano, C.; Rinaldi, C.; Barbone, F.; Fanin, R.
Journal:
Transplant infectious disease
Issue:
Volume 15:Issue 3(2013)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search